| Item 1. | |
| (a) | Name of issuer:
AN2 Therapeutics, Inc. |
| (b) | Address of issuer's principal executive offices:
1800 El Camino Real, Suite D, Menlo Park, CA 94027 |
| Item 2. | |
| (a) | Name of person filing:
This Schedule 13G is being filed jointly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"), Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"), Adjuvant Capital GP, L.P. ("AC GP") and Adjuvant Capital Management, L.L.C. ("AC Management" and together with AGHT Fund, AGHT Fund DE and AC GP, the "Reporting Persons").
AC GP is the sole general partner of AGHT Fund and the sole general partner of AGHT Fund DE, and may be deemed to beneficially own the shares of Common Stock beneficially owned by AGHT Fund and AGHT Fund DE. AC Management is the sole general partner of AC GP and may be deemed to beneficially own the shares of Common Stock beneficially owned by AGHT Fund and AGHT Fund DE. |
| (b) | Address or principal business office or, if none, residence:
The principal business address of each of the Reporting Persons, is c/o Adjuvant Capital, L.P., 500 Fifth Avenue, Suite 4000, New York, NY 10110. |
| (c) | Citizenship:
AGHT Fund is organized under the laws of the Cayman Islands. AGHT Fund DE, AC GP and AC Management are each organized under the laws of the State of Delaware. |
| (d) | Title of class of securities:
Common Stock, $0.00001 par value per share |
| (e) | CUSIP No.:
037326105 |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
| (a) |  Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
|
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
|
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
|
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
|
| (e) | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
|
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
|
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
|
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
|
| | |
| Item 4. | Ownership |
| (a) | Amount beneficially owned:
See rows 5 through 11 of the cover pages. |
| (b) | Percent of class:
See rows 5 through 11 of the cover pages. |
| (c) | Number of shares as to which the person has:
|
| | (i) Sole power to vote or to direct the vote:
See rows 5 through 11 of the cover pages.
|
| | (ii) Shared power to vote or to direct the vote:
See rows 5 through 11 of the cover pages.
|
| | (iii) Sole power to dispose or to direct the disposition of:
See rows 5 through 11 of the cover pages.
|
| | (iv) Shared power to dispose or to direct the disposition of:
See rows 5 through 11 of the cover pages.
|
| Item 5. | Ownership of 5 Percent or Less of a Class. |
| | |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. |
| |
Not Applicable
|
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
| |
Not Applicable
|
| Item 8. | Identification and Classification of Members of the Group. |
| |
Not Applicable
|
| Item 9. | Notice of Dissolution of Group. |
| |
Not Applicable
|
Rule 13d-1(d)